title: Titanium particles activate toll-like receptor 4 independently of lipid rafts in RAW264.7 murine macrophages.
abstract: Adherent pathogen-associated molecular patterns (PAMPs) act through toll-like receptor 2 (TLR2) and TLR4 to increase the biological activity of orthopedic wear particles in cell culture and animal models of implant loosening. This study tested whether this is dependent on TLR association with lipid rafts as reported for the response to soluble TLR ligands. For this purpose, RAW264.7 murine macrophages were activated by exposure to titanium particles with adherent PAMPs, soluble lipopolysaccharide (LPS), soluble lipotecichoic acid (LTA), or heat-killed bacteria that had been extensively washed to remove soluble PAMPs. Lipid rafts were isolated by two independent methods and the location of TLR4 and TLR2 was analyzed by Western blotting. The cognate TLRs associated with lipid rafts when the macrophages were activated with soluble LPS and LTA but not after stimulation with either titanium particles with adherent PAMPs or heat-killed bacteria. The lipid raft disruptor, methyl-β-cyclodextrin, dose-dependently inhibited TNF-α release in response to LPS but had no affect on TNF-α release in response to titanium particles with adherent PAMPs. We conclude, therefore, that titanium particles with adherent PAMPs and heat-killed bacteria activate TLR2 and TLR4 in macrophages without inducing either TLR to associate with lipid rafts. These results have important implications for the mechanisms of orthopedic implant loosening as well the mechanisms for TLR activation in other inflammatory situations.
authors.affiliation: Department of Orthopaedics, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, Ohio 44106-5000, USA. andrewislam@yahoo.com
authors.forename: Andrew S
authors.initials: AS
authors.lastname: Islam
authors.forename: Michelle A
authors.initials: MA
authors.lastname: Beidelschies
authors.forename: Anne
authors.initials: A
authors.lastname: Huml
authors.forename: Edward M
authors.initials: EM
authors.lastname: Greenfield
mesh_terms: D000818:Animals; D002460:Cell Line; D008262:Macrophage Activation; D008264:Macrophages / Q000187:drug effects / Q000378:metabolism; D021962:Membrane Microdomains / Q000187:drug effects*; D051379:Mice; D011475:Prosthesis Failure / Q000209:etiology*; D014025:Titanium / Q000009:adverse effects*; D051195:Toll-Like Receptor 2 / Q000378:metabolism; D051197:Toll-Like Receptor 4 / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*; D047392:beta-Cyclodextrins
chemical_list: C493486:Tlr2 protein, mouse; C493487:Tlr4 protein, mouse; D051195:Toll-Like Receptor 2; D051197:Toll-Like Receptor 4; D014409:Tumor Necrosis Factor-alpha; D047392:beta-Cyclodextrins; C108732:methyl-beta-cyclodextrin; D014025:Titanium
references.citation: J Orthop Res. 2002 Jan;20(1):1-8
references.pmid: 11855378
references.citation: J Biomed Mater Res A. 2007 Jun 15;81(4):1017-26
references.pmid: 17415764
references.citation: J Biomed Mater Res B Appl Biomater. 2005 Jan 15;72(1):179-85
references.pmid: 15449253
references.citation: Nat Immunol. 2010 May;11(5):373-84
references.pmid: 20404851
references.citation: J Leukoc Biol. 2009 Jun;85(6):905-10
references.pmid: 19276179
references.citation: J Am Acad Orthop Surg. 2008;16 Suppl 1:x-xi
references.pmid: 18612024
references.citation: Cell. 1992 Feb 7;68(3):533-44
references.pmid: 1531449
references.citation: Eur J Immunol. 2001 Nov;31(11):3153-64
references.pmid: 11745332
references.citation: J Orthop Res. 2007 Mar;25(3):361-9
references.pmid: 17106883
references.citation: Immunity. 1999 Oct;11(4):443-51
references.pmid: 10549626
references.citation: J Biol Chem. 2006 Oct 13;281(41):31002-11
references.pmid: 16880211
references.citation: J Cell Sci. 2002 Jun 15;115(Pt 12):2603-11
references.pmid: 12045230
references.citation: J Orthop Res. 2005 May;23(3):520-5
references.pmid: 15885470
references.citation: J Biol Chem. 2007 Feb 16;282(7):4669-4680
references.pmid: 17164250
references.citation: J Am Acad Orthop Surg. 2008;16 Suppl 1:S56-62
references.pmid: 18612015
references.citation: Nat Immunol. 2007 Jan;8(1):11-3
references.pmid: 17179963
references.citation: Biochem J. 2004 Jul 15;381(Pt 2):527-36
references.pmid: 15040785
references.citation: Biochem J. 1998 Sep 1;334 ( Pt 2):325-33
references.pmid: 9716490
references.citation: J Biol Chem. 2000 Jun 9;275(23):17221-4
references.pmid: 10770957
references.citation: J Orthop Res. 2005 Mar;23(2):376-83
references.pmid: 15734251
references.citation: J Exp Med. 2003 Oct 20;198(8):1225-35
references.pmid: 14568981
references.citation: Acta Orthop Scand. 2003 Dec;74(6):644-51
references.pmid: 14763692
references.citation: J Bone Miner Res. 2000 Dec;15(12):2391-401
references.pmid: 11127204
references.citation: Acta Orthop. 2006 Apr;77(2):177-97
references.pmid: 16752278
references.citation: Clin Orthop Relat Res. 2005 Aug;(437):25-30
references.pmid: 16056022
references.citation: J Bone Miner Res. 2001 Nov;16(11):2082-91
references.pmid: 11697805
references.citation: J Cell Physiol. 2007 Feb;210(2):428-35
references.pmid: 17111383
references.citation: Hypertension. 2006 Jan;47(1):74-80
references.pmid: 16344372
references.citation: J Biol Chem. 2010 Oct 15;285(42):32378-84
references.pmid: 20729214
references.citation: J Exp Med. 1999 Feb 15;189(4):615-25
references.pmid: 9989976
references.citation: J Biol Chem. 2004 Sep 24;279(39):40882-9
references.pmid: 15247273
references.citation: J Clin Invest. 2004 May;113(10):1482-9
references.pmid: 15146246
references.citation: Science. 1998 Dec 11;282(5396):2085-8
references.pmid: 9851930
references.citation: J Cell Physiol. 2008 Dec;217(3):652-66
references.pmid: 18651635